Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors

Patent metadata

Field	Value
Publication number	US-12319685-B2
Application number	US-201917268983-A
Country	US
Kind code	B2
Filing date	Aug 15, 2019
Priority date	Aug 17, 2018
Publication date	Jun 3, 2025
Grant date	Jun 3, 2025

Abstract

Disclosed herein are small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors.

First claim

What is claimed is:

1. A compound, having a structure defined by Formula I or a pharmaceutically acceptable salt thereof:

wherein A 1 is selected from O, CH 2 , S, or NH;
A 2 is N;
A 3 , A 4 , A 5 , A 6 , or A 7 are independently selected from C, S, N;
R′ and R″ are independently selected from hydrogen or unsubstituted C 1 -C 6 alkyl or both R′ and R″ combine to form a substituted or unsubstituted C 2 -C 7 heterocycloalkyl or a substituted or unsubstituted C 2 -C 7 heterocycloalkenyl together with the atom to which they are attached;
R′″ and R iv are independently selected from hydrogen; hydroxyl, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted aminoalkyl, substituted or unsubstituted C 1 -C 6 haloalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloheteroalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or both R′″ and R iv combine to form a substituted or unsubstituted C 2 -C 7 heterocycloalkyl or a substituted or unsubstituted C 2 -C 7 heterocycloalkenyl together with the atom to which they are attached;
R 1 is null or selected from hydrogen; hydroxyl, halide, substituted or unsubstituted nitrile, substituted or unsubstituted nitro, substituted or unsubstituted amine, substituted or unsubstituted alkyl halide, substituted or unsubstituted carboxyl, substituted or unsubstituted amide, substituted or unsubstituted ester, substituted or unsubstituted ether, substituted or unsubstituted ketone, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted C 2 -C 6 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted silyl, substituted or unsubstituted sulfonyl, substituted or unsubstituted sulfone, substituted or unsubstituted sulfoxide, or substituted or unsubstituted thiol; and
R 2 -R 5 are independently null or independently selected from hydrogen; hydroxyl, halide, substituted or unsubstituted nitrile, substituted or unsubstituted nitro, substituted or unsubstituted amine, substituted or unsubstituted alkyl halide, substituted or unsubstituted carboxyl, substituted or unsubstituted amide, substituted or unsubstituted ester, substituted or unsubstituted ether, substituted or unsubstituted ketone, substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted C 2 -C 6 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted silyl, substituted or unsubstituted sulfonyl, substituted or unsubstituted sulfone, substituted or unsubstituted sulfoxide, or substituted or unsubstituted thiol.

2. The compound of claim 1 , having a structure defined by Formula I-B-1 or a pharmaceutically acceptable salt thereof:

3. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein A 1 is NH.

4. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein A 3 is selected from C or N.

5. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R′ and R″ are independently selected from hydrogen and unsubstituted C 1 -C 6 alkyl or both R′ and R″ combine to form a substituted or unsubstituted C 2 -C 7 heterocycloalkyl together with the atom to which they are attached.

6. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R′″ is hydrogen and R iv is independently selected from hydrogen; substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted aminoalkyl, substituted or unsubstituted C 1 -C 6 haloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloheteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or
both R′″ and R iv combine to form a substituted or unsubstituted C 2 -C 7 heterocycloalkyl or a substituted or unsubstituted C 2 -C 7 heterocycloalkenyl together with the atom to which they are attached.

7. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 1 is selected from hydrogen; hydroxyl, halide, unsubstituted nitrile, unsubstituted nitro, unsubstituted amine, unsubstituted alkyl halide, unsubstituted carboxyl, unsubstituted amide, unsubstituted ester, unsubstituted ether, unsubstituted C 1 -C 6 alkyl, unsubstituted alkoxy, unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or unsubstituted thiol.

8. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 is selected from hydrogen; hydroxyl, halide, unsubstituted nitrile, unsubstituted nitro, unsubstituted amine, unsubstituted alkyl halide, unsubstituted carboxyl, unsubstituted amide, unsubstituted ester, unsubstituted ether, unsubstituted C 1 -C 6 alkyl, unsubstituted alkoxy, unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or unsubstituted thiol.

9. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 3 is selected from hydrogen; hydroxyl, halide, unsubstituted nitrile, unsubstituted nitro, unsubstituted amine, unsubstituted alkyl halide, unsubstituted carboxyl, unsubstituted amide, unsubstituted ester, unsubstituted ether, unsubstituted C 1 -C 6 alkyl, unsubstituted alkoxy, unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or unsubstituted thiol.

10. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 4 is selected from hydrogen; hydroxyl, halide, unsubstituted nitrile, unsubstituted nitro, unsubstituted amine, unsubstituted alkyl halide, unsubstituted carboxyl, unsubstituted amide, unsubstituted ester, unsubstituted ether, unsubstituted C 1 -C 6 alkyl, unsubstituted alkoxy, unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or unsubstituted thiol.

11. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 5 is selected from hydrogen; hydroxyl, halide, unsubstituted nitrile, unsubstituted nitro, unsubstituted amine, unsubstituted alkyl halide, unsubstituted carboxyl, unsubstituted amide, unsubstituted ester, unsubstituted ether, unsubstituted C 1 -C 6 alkyl, unsubstituted alkoxy, unsubstituted C 2 -C 6 alkenyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or unsubstituted thiol.

12. The compound of claim 1 , or a pharmaceutically acceptable salt thereof, wherein R 2 -R 5 are independently selected from hydrogen; halide, or unsubstituted C 1 -C 6 alkyl.

13. The compound of claim 1 , having a structure selected from Formula 6a-6x

6a-x

Formula
NR 1 R 2
NR 3 R 4

Assignees

• H Lee Moffitt Cancer Ct & Res

Inventors

• List Alan
• Ji Haitao

Classifications

• C07D519/00

  Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

• C07D277/68

  with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 · CPC title

• C07D277/56

  Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen · CPC title

• C07D213/85

  in position 3 · CPC title

• A61K45/06

  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title